BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection
Form 7 Monthly Progress Report December 2025 Name of Listed Issuer: Trading Symbol: Number of
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors Expanding U.S. market
BioMark: 2025 Achievements & 2026 Vision Celebrating A Year of Extraordinary Achievement VANCOUVER, BRITISH COLUMBIA
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2